Christopher M. Smith

This profile gathers the share dealings of Christopher M. Smith across 6 companies, led by Neogenomics Inc, Ortho Clinical Diagnostics Holdings plc and QuidelOrtho Corp. Between 7 June 2010 and 23 February 2025, the trades on record add up to 25 filings.

Market trades split into 1 purchase (€242.3M) and 4 sales (€6.8M). On balance, insiders were net buyers of €235.5M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 14 share grants and 5 option exercises.

Most recently, on 25 February 2025, the filings show a share grant in Neogenomics Inc. The clock since the last published purchase (8 May 2014) now reads 4,551 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.